Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : RRRRRRReport on one case and review of other uses in acute leukemias

Medical Oncology

Volumn 27, Issue 1, 2010, Pages 16-19

  Pamuk, Gülsüm Emel ^a,b   Taşçi, Murat ^a   Öztürk, Erman ^a   Demir, Muzaffer ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Acute myeloid leukemia; Gastrointestinal bleeding; Recombinant activated factor VII (rFVIIa); Thrombocytopenia

Indexed keywords

ACICLOVIR; AMPHOTERICIN B DEOXYCHOLATE; CYTARABINE; FRESH FROZEN PLASMA; IDARUBICIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PROTON PUMP INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TEICOPLANIN;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADD ON THERAPY; ADULT; APHERESIS; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATEMESIS; HUMAN; INTESTINE ISCHEMIA; LABORATORY TEST; MELENA; MULTIPLE CYCLE TREATMENT; NAUSEA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; TREATMENT RESPONSE; TYPHILITIS; VOMITING;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FACTOR VIIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; IDARUBICIN; INJECTIONS, INTRAVENOUS; LEUKEMIA, MYELOID, ACUTE; RECOMBINANT PROTEINS; REMISSION INDUCTION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 77949269590     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9163-y     Document Type: Article

References (30)

1. British Society of Gastroenterology Endoscopy Committee 2002 Non-variceal upper gastrointestinal haemorrhage: guidelines Gut 52 SIV 1 6 iv
2. CS Huang DR Lichtenstein 2003 Nonvariceal upper gastrointestinal bleeding Gastroenterol Clin N Am 32 1053 78 10.1016/S0889-8553(03)00092-X 10.1016/S0889-8553(03)00092-X (Pubitemid 37532289)
3. HJ Dallal KR Palmer 2001 ABC of the upper gastrointestinal tract: upper gastrointestinal haemorrhage BMJ 323 1115 7 10.1136/bmj.323.7321.1115 10.1136/bmj.323.7321.1115 1:STN:280:DC%2BD3MnkvV2rsA%3D%3D 11701581
4. AD Shapiro 2000 Recombinant factor VIIa in the treatment of bleeding in hemophiliac children with inhibitors Semin Thromb Hemost 26 413 9 10.1055/s-2000-8461 10.1055/s-2000-8461 1:CAS:528:DC%2BD3cXosFSgur0%3D 11092217
5. M Levi M Peters HR Buller 2005 Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review Crit Care Med 33 883 90 10.1097/01.CCM.0000159087.85970.38 10.1097/01.CCM.0000159087.85970.38 1:CAS:528:DC%2BD2MXjtVOjsbo%3D 15818119
6. GT Gerotziafas K Zervas P Arzoglou E Karavaggeli S Parashou, et al. 2002 On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening hemorrhage: focus on prothrombin activation Br J Haematol 117 705 8 10.1046/j.1365-2141.2002.03437.x 10.1046/j.1365-2141.2002.03437.x 1:CAS:528:DC%2BD38Xlt1CqsLc%3D 12028045 (Pubitemid 34539250)
7. RT Yavorski RK Wong C Maydonovitch LS Battin A Furnia, et al. 1995 Analysis of 3294 cases of upper gastrointestinal bleeding in military medical facilities Am J Gastroenterol 90 568 73 1:STN:280:DyaK2M3jtlensQ%3D%3D 7717312
8. M Franchini D Veneri G Lippi 2007 The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review Bone Marrow Transplant 39 729 35 10.1038/sj.bmt.1705670 10.1038/sj.bmt.1705670 1:CAS:528:DC%2BD2sXmtFSjsLg%3D 17417659 (Pubitemid 46901970)
9. M Hoffman DM Monroe III HR Roberts 1998 Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII Blood Coagul Fibrinolysis 9 Suppl 1 S61 5 1:CAS:528:DyaK1cXnsVCisLY%3D 9819030
10. DM Monroe M Hoffman JA Oliver HR Roberts 1998 A possible mechanism of action of activated factor VII independent of tissue factor Blood Coagul Fibrinolysis 9 Suppl 1 S15 20 1:CAS:528:DyaK1cXnsVCisLw%3D 9819024
11. U Hedner 2000 NovoSeven as a universal hemostatic agent Blood Coagul Fibrinolysis 11 Suppl 1 S107 11 10.1097/00001721-200011010-00012 1:CAS:528:DC%2BD3cXktlGitr0%3D 10850574
12. AD Shapiro 1996 American experience with home use of NovoSeven: recombinant factor VIIa in hemophiliacs with inhibitors Hemostasis 26 Suppl 1 143 9 1:CAS:528:DyaK28XitlKrsr8%3D
13. M Heller W Lau R Pazmino-Canizares L Brandao M Carcao 2008 A Comprehensive Review of rFVIIa Use in a Tertiary Care Pediatric Cancer Pediatr Blood Cancer 50 1013 7 10.1002/pbc.21375 10.1002/pbc.21375 17960639
14. J Kristensen A Killander E Hippe C Helleberg J Ellegard, et al. 1996 Clinical experience with recombinant factor VIIa in patients with thrombocytopenia Haemostasis 26 Suppl 1 159 64 1:CAS:528:DyaK28XitlKrsro%3D 8904193
15. B White M Martin S Kelleher P Browne SR McCann, et al. 1999 Successful use of recombinant FVIIa (Novoseven) in the management of pulmonary haemorrhage secondary to Aspergillus infection in a patient with leukemia and acquired FVII deficiency Br J Haematol 106 254 5 10.1046/j.1365-2141.1999.01562.x 10.1046/j.1365-2141.1999.01562.x 1:STN:280:DyaK1MzntlGrsQ%3D%3D 10444198 (Pubitemid 29343562)
16. K Meijer WE de Graaff SM Daenen J van der Meer 2000 Successful treatment of massive hemoptysis in acute leukemia with recombinant factor VIIa Arch Intern Med 160 2216 7 10.1001/archinte.160.14.2216 10.1001/archinte.160.14.2216 1:STN:280:DC%2BD3czptVKmsA%3D%3D 10904466
17. J Blatt SH Gold JM Wiley PE Monahan HC Cooper, et al. 2001 Off-label use of recombinant factor VIIa in patients following bone marrow transplantation Bone Marrow Transplant 28 405 7 10.1038/sj.bmt.1703157 10.1038/sj.bmt.1703157 1:STN:280:DC%2BD3MritlSjtA%3D%3D 11571515 (Pubitemid 32834361)
18. K Hicks D Peng JL Gajewski 2002 Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa Bone Marrow Transplant 30 975 8 10.1038/sj.bmt.1703731 10.1038/sj.bmt.1703731 1:STN:280:DC%2BD3s%2FhvFCmsQ%3D%3D 12476294 (Pubitemid 36097490)
19. P Eller C Pechlaner CJ Wiedermann 2006 Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation- related gastrointestinal bleeding Thromb J 4 1 10.1186/1477-9560-4-1 10.1186/1477-9560-4-1 1:STN:280:DC%2BD1c7ntFSlsw%3D%3D 16420687 (Pubitemid 43264332)
20. A Shenov BN Savani AJ Barrett 2007 Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation Biol Blood Marrow Transplant 13 622 3 10.1016/j.bbmt.2007.01.070 10.1016/j.bbmt.2007. 01.070 (Pubitemid 46585931)
21. R Hoffman R Eliakim T Zuckerman JM Rowe B Brenner 2003 Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia J Thromb Haemost 1 606 8 10.1046/j.1538-7836.2003.t01-5-00177.x 10.1046/j.1538-7836.2003.t01-5-00177.x 1:STN:280:DC%2BD3szjvFGqug%3D%3D 12871480
22. B Zulfikar SM Kayran 2004 Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven) Blood Coagul Fibrinolysis 15 261 3 10.1097/00001721- 200404000-00011 10.1097/00001721-200404000-00011 15060424 (Pubitemid 38561555)
23. AE Kurekci AA Atay V Okutan ST Yavuz O Ozcan 2005 Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia Blood Coagul Fibrinolysis 16 145 7 10.1097/01.mbc.0000161569.66764.70 10.1097/01.mbc.0000161569.66764.70 15741803
24. G Mantzios P Tsirigotis V Pappa K Spirou V Giannopoulou, et al. 2007 Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding Eur J Haematol 78 173 4 17313564
25. W Osborne S Bhandari RC Tait IM Franklin 2004 Immediate hemostasis with recombinant factor VIIa for hemorrhage following Hickman line insertion in acute myeloid leukemia Clin Lab Haematol 26 229 31 10.1111/j.1365-2257.2004.00604.x 10.1111/j.1365-2257.2004.00604.x 1:STN:280:DC%2BD2c3msV2hug%3D%3D 15163323 (Pubitemid 38736868)
26. D Veneri M Franchini 2005 Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient Am J Hematol 79 344 5 10.1002/ajh.20345 10.1002/ajh.20345 16044447 (Pubitemid 41098857)
27. C Ucar U Caliskan 2006 Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child Pediatr Hematol Oncol 23 339 45 10.1080/08880010600631987 10.1080/08880010600631987 16621776
28. AA Erikci A Ozturk O Sayan 2006 Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia Blood Coagul Fibrinolysis 17 323 4 10.1097/01.mbc.0000224854.88366.05 10.1097/01.mbc.0000224854.88366.05 16651877 (Pubitemid 43756130)
29. S Zver D Andoljsek P Cernelc 2004 Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukemia Eur J Haematol 72 455 6 10.1111/j.1600-0609.2004.00237.x 10.1111/j.1600-0609.2004.00237.x 15128428 (Pubitemid 38703541)
30. K Alimoghaddam A Ghavamzadeh M Jahani 2006 Use of Novoseven for arsenic trioxide-induced bleeding in PML Am J Hematol 81 720 10.1002/ajh.20713 10.1002/ajh.20713 16804937 (Pubitemid 44306834)